top of page
press releases
Glox Therapeutics Strengthens Team Appointing Dr Michael Murray as Chair and Dr Nel Moore as Scientific Advisory Board Member
Expanded team to support development and commercialisation of precision antibiotics to help overcome antimicrobial resistance Glasgow,...
Feb 11
Glox Therapeutics Awarded Share of £3M Collaborative Discovery Programme Funding from Cystic Fibrosis Antimicrobial Resistance Syndicate
£500K grant to advance discovery and development of effective precision antibiotics targeting antimicrobial-resistant lung infections in...
Jan 21
Glox Therapeutics Awarded £1M PACE Grant to Accelerate Development of Precision Antibiotics Against Antimicrobial-resistant Pathogens
Novel therapeutics to address unmet clinical need for pneumonias caused by drug-resistant Escherichia coli and Klebsiella pneumoniae PACE...
Nov 20, 2024
Glox Therapeutics Secures £4.3M Seed Funding to Develop Precision Antimicrobials
...Targeting Drug-resistant Bacteria Investment to accelerate development of a novel class of targeted high-potency bacteriocins against...
Nov 14, 2023
bottom of page